{
    "clinical_study": {
        "@rank": "57007", 
        "arm_group": [
            {
                "arm_group_label": "Active / control", 
                "arm_group_type": "Active Comparator", 
                "description": "One side has been treated with SurgiShield"
            }, 
            {
                "arm_group_label": "No intervention", 
                "arm_group_type": "No Intervention", 
                "description": "One side has no intervention"
            }
        ], 
        "brief_summary": {
            "textblock": "This clinical trial is intended to evaluate the impact, efficacy, and safety of Chitosan\n      formulated adhesion inhibitor, SurgiShield when used in the process of wound healing after\n      endoscopic sinus surgery."
        }, 
        "brief_title": "Efficacy and Safety of the Investigational Device, SurgiShield Anti-Adhesion Barrier Gel", 
        "completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "condition": "Wound Healing", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  older than 21 years of age\n\n          -  both side sinusitis\n\n          -  will undergo endoscopic sinus surgery\n\n          -  volunteers with informed consent and signature\n\n        Exclusion Criteria:\n\n          -  suppressed immunity patient\n\n          -  systemic grave condition\n\n          -  pregnant\n\n          -  cancer\n\n          -  severe disease patients\n\n          -  asthma patients\n\n          -  AIDS\n\n          -  cystic fibrosis\n\n          -  ciliary immobility syndrome\n\n          -  neutropenia neutrophil\n\n          -  immunoglobulin deficiency\n\n          -  wound healing immune disease\n\n          -  severe liver disease\n\n          -  severe kidney disease\n\n          -  lymph or blood clotting disorder or patients treated with coagulants\n\n          -  patients taking oral or parenteral glucose for diabetes thrombocytopenia\n\n          -  infectious disease\n\n          -  currently lactating\n\n          -  severe septal deviation\n\n          -  case where there is a severe difference in sinusitis state between sides of nose:\n             there is a 3 or more score difference on the Lund-Mackey CT scan scoring system\n             PNS(ParaNasalSinus)\n\n          -  shellfish allergy\n\n          -  food allergy\n\n          -  had endoscopic sinus surgery in the past\n\n          -  patient with large sinus polyps\n\n          -  patients who have received treatment for extrasinus complication"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "33", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "July 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01895933", 
            "org_study_id": "DMED-SS001"
        }, 
        "intervention": {
            "arm_group_label": "Active / control", 
            "description": "in the case of active, apply solution type adhesion barrier to merocel and pack 5ml of adhesion inhibitor Surgi Shield on the surgical site\nmerocel in the inflated state maintained for 36~48 hours, remove packing then solution type adhesion inhibitor is to be injected in to the surgical site", 
            "intervention_name": "5ml surgishield", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Investigational device (chitosan gel)", 
            "Wound healing", 
            "Endoscopic sinus surgery", 
            "SurgiShield"
        ], 
        "lastchanged_date": "July 21, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "ChungJu", 
                        "country": "Korea, Republic of", 
                        "state": "ChoongChungBukDo"
                    }, 
                    "name": "Chungbook National University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "ChunAhn", 
                        "country": "Korea, Republic of", 
                        "state": "ChoongChungNamDo"
                    }, 
                    "name": "Dankook University Hospital"
                }
            }
        ], 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Aim of This Study is to Evaluate the Efficacy and Safety of the Investigational Device, SurgiShield Anti-Adhesion Barrier Gel Made by D Med", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "South Korea: Institutional Review Board", 
                "South Korea: Korea Food and Drug Administration (KFDA)"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Adhesion rate at 2 weeks after ESS(endoscopic sinus surgery)", 
            "measure": "Adhesion Rate", 
            "safety_issue": "No", 
            "time_frame": "at 2 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01895933"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Adhesion rate at 1 and 4 weeks after ESS(endoscopic sinus surgery) Bleeding score at 0,2,4,6,8,10 minutes after ESS", 
            "measure": "Adhesion Rate", 
            "safety_issue": "No", 
            "time_frame": "at 1 and 4 weeks"
        }, 
        "source": "D.med", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Dankook University", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Chungbuk National University", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "D.med", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}